JAZZ

Jazz Pharmaceuticals plc (Ireland) (JAZZ)

About Jazz Pharmaceuticals plc (Ireland) (JAZZ)

Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio. The company was founded by Bruce C. Cozadd in March 2003 and is headquartered in Dublin, Ireland.

Details

Daily high

$111.00

Daily low

$108.93

Price at open

$109.07

52 Week High

$137.38

52 Week Low

$99.06

Market cap

6.7B

Dividend yield

0.00%

Volume

314,422

Avg. volume

605,184

P/E ratio

19.44

Jazz Pharmaceuticals plc (Ireland) News